日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralization

来自新冠肺炎康复患者的单克隆抗体靶向隐蔽表位,可广泛中和SARS-CoV-2病毒

Harit, Aakanksha; Mor, Michael; Yefet, Ron; Izhaki-Tavor, Lee S; Gal-Tanamy, Meital; Freund, Natalia T; Dessau, Moshe

Silent mutations in coding regions of Hepatitis C virus affect patterns of HCV RNA structures and attenuate viral replication and pathogenesis

丙型肝炎病毒编码区的沉默突变会影响HCV RNA的结构模式,并减弱病毒复制和致病性。

Dabour, Roba; Bergman, Shaked; Zafrir, Zohar; Davidovitch, Ateret; Werbner, Michal; Gal-Tanamy, Meital; Tuller, Tamir

Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication

后直接抗病毒药物时代尚未满足的需求:丙型肝炎病毒根除后肝细胞癌的风险和分子机制

Huang, Chung-Feng; Awad, Manar Hijaze; Gal-Tanamy, Meital; Yu, Ming-Lung

Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on "Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication"

后直接抗病毒药物时代丙型肝炎病毒根除后肝细胞癌的风险和分子机制展望:对题为“后直接抗病毒药物时代未满足的需求:丙型肝炎病毒根除后肝细胞癌的风险和分子机制”的社论的回应

Huang, Chung-Feng; Awad, Manar Hijaze; Gal-Tanamy, Meital; Yu, Ming-Lung

Maternal-Fetal Transfer of Anti-SARS-CoV-2 Antibodies in Amniotic Fluid: Insights from Maternal Vaccination and COVID-19 Infection

母胎间通过羊水转移抗SARS-CoV-2抗体:来自孕妇接种疫苗和COVID-19感染的启示

Sgayer, Inshirah; Odeh, Marwan; Gal-Tanamy, Meital; Shehadeh, Mona; Rechnitzer, Hagai; Haddad, Yousef; Hamoudi, Rudi; Mousa, Nisreen Kinaani; Dakwar, Vivian Abu Uksa; Wolf, Maya Frank; Falik Zaccai, Tzipora C; Lowenstein, Lior

High-Resolution Genomic Profiling of Liver Cancer Links Etiology With Mutation and Epigenetic Signatures

肝癌高分辨率基因组分析揭示病因与突变和表观遗传特征之间的联系

Perez, Shira; Lavi-Itzkovitz, Anat; Gidoni, Moriah; Domovitz, Tom; Dabour, Roba; Khurana, Ishant; Davidovich, Ateret; Tobar, Ana; Livoff, Alejandro; Solomonov, Evgeny; Maman, Yaakov; El-Osta, Assam; Tsai, Yishan; Yu, Ming-Lung; Stemmer, Salomon M; Haviv, Izhak; Yaari, Gur; Gal-Tanamy, Meital

Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα

接受抗TNFα治疗的炎症性肠病患者对COVID-19 mRNA疫苗的血清学反应较低

Edelman-Klapper, Hadar; Zittan, Eran; Bar-Gil Shitrit, Ariella; Rabinowitz, Keren Masha; Goren, Idan; Avni-Biron, Irit; Ollech, Jacob E; Lichtenstein, Lev; Banai-Eran, Hagar; Yanai, Henit; Snir, Yifat; Pauker, Maor H; Friedenberg, Adi; Levy-Barda, Adva; Segal, Arie; Broitman, Yelena; Maoz, Eran; Ovadia, Baruch; Golan, Maya Aharoni; Shachar, Eyal; Ben-Horin, Shomron; Perets, Tsachi-Tsadok; Ben Zvi, Haim; Eliakim, Rami; Barkan, Revital; Goren, Sophy; Navon, Michal; Krugliak, Noy; Werbner, Michal; Alter, Joel; Dessau, Moshe; Gal-Tanamy, Meital; Freund, Natalia T; Cohen, Dani; Dotan, Iris

P342 Trans-continental analysis of over, 2000 Inflammatory Bowel Disease patients implicates geography, disease type, and exposure to immunosuppression as drivers of SARS-CoV-2 seroprevalence: data from the ICARUS-IBD Consortium

P342 对超过 2000 名炎症性肠病患者的跨大陆分析表明,地理位置、疾病类型和免疫抑制暴露是 SARS-CoV-2 血清阳性率的驱动因素:来自 ICARUS-IBD 联盟的数据

Waljee, Akbar K; Sauder, Kay; Patel, Anand; Segar, Sandeep; Zhang, Yiwei; Zhu, Ji; Stidham, Ryan W; Balis, Ulysses; Higgins, Peter D R; Rabinowitz, K M; Navon, M; Edelman-Klapper, H; Zittan, E; Bar-Gil Shitrit, A; Goren, I; Avni-Biron, I; Ollech, J E; Lichtenstein, L; Banai-Eran, H; Yanai, H; Snir, Y; Pauker, M H; Friedenberg, A; Levy-Barda, A; Segal, A; Broitman, Y; Maoz, E; Ovadia, B; Aharoni Golan, M; Shachar, E; Ben-Horin, S; Perets, T T; Ben Zvi, H; Eliakim, R; Barkan, R; Goren, S; Krugliak, N; Werbner, M; Alter, J; Dessau, M; Gal-Tanamy, M; Cohen, D; Freund, N T; Dotan, I; Attauabi, M; Dahlerup, J F; Poulsen, A; Hansen, M R; Vester-Andersen, M K; Eraslan, S; Prahm, A P; Pedersen, N; Larsen, L; Jess, T; Neumann, A; Haderslev, K V; Molazahi, A; Lødrup, A B; Glerup, H; Oppfeldt, A M; Jensen, M D; Theede, K; Kiszka-Kanowitz, M; Seidelin, J B; Burisch, J; Jørgensen, K K; Syversen, S W; Jyssum, I; Tveter, A T; Tran, T T; Sexton, J; Provan, S A; Mjaaland, S; Warren, D J; Kvien, T K; Grødeland, G; Nissen-Meyer, L S; Ricanek, P; Chopra, A; Andersson, A M; Kro, G B; Jahnsen, J; Munthe, L A; Haavardsholm, E A; Vaage, J T; Lund-Johansen, F; Goll, G L; Attauabi, M; Dahlerup, J F; Poulsen, A; Hansen, M R; Vester-Andersen, M K; Eraslan, S; Prahm, A P; Pedersen, N; Larsen, L; Jess, T; Neumann, A; Haderslev, K V; Molazahi, A; Lødrup, A B; Glerup, H; Oppfeldt, A M; Jensen, M D; Theede, K; Kiszka-Kanowitz, M; Seidelin, J B; Burisch, J; Wong, S Y; Helmus, D; Marlow, L; Martinez Pazos, V; Brann, S; Wellens, J; Kedia, S; Mak, J W Y; Bergemalm, D; Argollo, M; Zaltman, C; Steinwurz, F; Rubin, D; Allez, M; Halfvarson, J; Abreu, M T; Lindsay, J; Dutta, U; Silverberg, M S; Ng, S C; Ahuja, V; Watanabe, K; Vermeire, S; Colombel, J F; Satsangi, J

Rapid electrochemical immunodetection of SARS-CoV-2 using a pseudo-typed vesicular stomatitis virus model

使用假型水泡性口炎病毒模型快速电化学免疫检测 SARS-CoV-2

Idan Ashur, Joel Alter, Michal Werbner, Abraham Ogungbile, Moshe Dessau, Meital Gal-Tanamy, Sefi Vernick

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies

自然诱导的抗 SARS-CoV-2 抗体中和 SARS-CoV-2 的构象灵活性

Ruofan Li #, Michael Mor #, Bingting Ma #, Alex E Clark, Joel Alter, Michal Werbner, Jamie Casey Lee, Sandra L Leibel, Aaron F Carlin, Moshe Dessau, Meital Gal-Tanamy, Ben A Croker, Ye Xiang, Natalia T Freund